UNICA IRIS Institutional Research Information System

PEIRETTI, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 110.023
NA - Nord America 7.266
AS - Asia 3.785
SA - Sud America 752
AF - Africa 157
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 3
Totale 122.031
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 107.812
US - Stati Uniti d'America 7.077
SG - Singapore 1.484
CN - Cina 1.135
BR - Brasile 585
SE - Svezia 541
UA - Ucraina 350
VN - Vietnam 331
DE - Germania 297
GB - Regno Unito 256
FI - Finlandia 194
FR - Francia 177
IN - India 172
HK - Hong Kong 132
CA - Canada 102
NL - Olanda 101
BD - Bangladesh 56
KR - Corea 55
MX - Messico 54
AR - Argentina 52
ZA - Sudafrica 44
ES - Italia 43
AU - Australia 40
TR - Turchia 40
IQ - Iraq 39
PH - Filippine 39
RU - Federazione Russa 39
ID - Indonesia 35
PK - Pakistan 35
CH - Svizzera 30
PL - Polonia 30
AT - Austria 28
CL - Cile 27
JP - Giappone 27
TW - Taiwan 26
BE - Belgio 23
EG - Egitto 23
IR - Iran 22
SA - Arabia Saudita 22
VE - Venezuela 21
CO - Colombia 20
EC - Ecuador 19
MY - Malesia 18
MA - Marocco 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
UZ - Uzbekistan 14
TN - Tunisia 13
GR - Grecia 12
IE - Irlanda 12
AZ - Azerbaigian 11
PY - Paraguay 11
ET - Etiopia 10
MU - Mauritius 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
HR - Croazia 8
IL - Israele 8
OM - Oman 8
PE - Perù 8
KZ - Kazakistan 7
LT - Lituania 7
LY - Libia 7
NG - Nigeria 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
NO - Norvegia 6
NP - Nepal 6
RO - Romania 6
BO - Bolivia 5
HU - Ungheria 5
KE - Kenya 5
RS - Serbia 5
AL - Albania 4
AM - Armenia 4
BN - Brunei Darussalam 4
CR - Costa Rica 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PA - Panama 4
SN - Senegal 4
TH - Thailandia 4
UY - Uruguay 4
CI - Costa d'Avorio 3
HN - Honduras 3
JM - Giamaica 3
KH - Cambogia 3
LB - Libano 3
LI - Liechtenstein 3
LK - Sri Lanka 3
TT - Trinidad e Tobago 3
YE - Yemen 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GH - Ghana 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
Totale 122.006
Salva come PNG Salva come JPEG
Città #
Cagliari 103.426
Uta 3.869
Singapore 784
Ashburn 746
Fairfield 602
Woodbridge 437
Chandler 399
Dallas 373
San Jose 366
Nyköping 356
Houston 337
Boardman 313
Wilmington 268
Seattle 258
Ann Arbor 237
Cambridge 227
Beijing 215
Jacksonville 179
Los Angeles 139
Santa Clara 123
Council Bluffs 121
Dearborn 115
Helsinki 112
Hong Kong 112
Lauterbourg 104
New York 104
Shanghai 103
The Dalles 96
Hefei 94
Ho Chi Minh City 94
Boston 73
Hanoi 69
Nanjing 61
Milan 58
Seoul 53
São Paulo 52
Buffalo 50
Rome 42
Chicago 38
Orem 36
San Diego 36
Redondo Beach 33
Munich 31
London 28
Toronto 27
Dong Ket 26
Redwood City 25
Sassari 24
Shenyang 24
Nuremberg 23
Selargius 22
Guangzhou 21
Tokyo 21
Chennai 20
Frankfurt am Main 20
Johannesburg 20
Nanchang 20
Hebei 19
Warsaw 19
Amsterdam 18
Montreal 18
Tianjin 18
Haiphong 17
Phoenix 17
Atlanta 16
Cedar Knolls 16
Jiaxing 16
Rio de Janeiro 16
Yverdon 16
Baghdad 15
Brooklyn 15
Manchester 15
Mumbai 15
Brussels 14
Changsha 14
Denver 14
Augusta 13
Curitiba 13
Poplar 13
Slough 13
Zhengzhou 13
Amman 12
Da Nang 12
Mountain View 12
Shenzhen 12
Stockholm 12
Ardabil 11
Belo Horizonte 11
Mexico City 11
Moscow 11
Norwalk 11
Paris 11
Querétaro 11
San Mateo 11
Tashkent 11
Dhaka 10
Guayaquil 10
Madrid 10
Miami 10
Orange 10
Totale 116.244
Salva come PNG Salva come JPEG
Nome #
null 3.998
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.190
null 2.985
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.875
Pterygium and glucose-6-phosphate dehydrogenase deficiency 2.864
OCT angiography characteristics in patients with chronic CSCR complicated with polypoidal choroidal vasculopathy 2.133
Comparison of inverted flap and subretinal aspiration technique in full-thickness macular hole surgery: a randomized controlled study 2.001
Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics 1.991
mRNA Level Alterations Of Protein Involved In Cholesterol Ester Metabolism In Pterygium Fibroblast 1.900
Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts 1.755
Influence of macular choroidal thickness on visual function in highly myopic eyes 1.748
Use of a new intra-ocular spectral domain optical coherence tomography in vitreoretinal surgery 1.740
Novel P.Asp304gly mutation in best1 gene associated with atypical best vitelliform macular dystrophy phenotype and high intrafamilial variability 1.737
Photodynamic Therapy with Verteporfin for Corneal Neovascularization 1.714
Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: A prospective study of elective cases 1.699
Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. 1.686
Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy 1.655
null 1.601
Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy 1.551
Terapia Fotodinamica dello Pterigio con Verteporfina 1.537
Unilateral retinitis pigmentosa: A proposal of genetic pathogenic mechanisms 1.533
Infrared imaging of choroidal involvement in Leber's idiopathic stellate neuroretinitis 1.516
Bilateral noncalcified astrocytic hamartomas in retinitis pigmentosa: Multimodal imaging evaluation over 8 years of follow-up 1.513
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY SECONDARY TO CHRONIC CENTRAL SEROUS CHORIORETINOPATHY 1.498
Proliferative Activity and Cholesterol Ester Metabolism in Primary Culture of Human Pterygium Fibroblasts 1.497
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 1.492
HUMAN AMNIOTIC MEMBRANE TO CLOSE RECURRENT, HIGH MYOPIC MACULAR HOLES IN PATHOLOGIC MYOPIA WITH AXIAL LENGTH OF ≥30 mm 1.464
Strategy for the management of diabetic macular edema: the European Vitreo-Retinal Society macular edema study 1.463
Current surgical treatment of age-related macular degeneration 1.461
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 1.452
Analysis of Fundus Autofluorescence in Patients with Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 1.432
Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy 1.420
Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy 1.412
An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study 1.382
Antiproliferative drugs reduce pterygium fibroblast growth rate by modulating cholesterol homeostasis 1.370
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 1.358
null 1.350
Correspondence 1.346
Efficacy and safety of combined vitrectomy with intravitreal dexamethasone implant for advanced stage epiretinal membrane 1.273
Reliable Therapeutic Modalities to Treat Age-Related Macular Degeneration 1.264
Negative correlation between retinal displacement and ganglion cell layer thickness changes in eyes with epiretinal membrane 1.226
Polypoidal choroidal vasculopathy in association with choroidal nevus 1.223
Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-loaded Erythrocyte Ghost Cells. 1.195
Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy 1.194
Primary vitreoretinal lymphoma masquerading as acute posterior multifocal placoid pigment epitheliopathy 1.190
Evaluation of the Choroid in Eyes With Retinitis Pigmentosa and Cystoid Macular Edema 1.176
Polypoidal choroidal vasculopathy associated with tilted disc syndrome 1.142
The nature and frequency of neovascular age-related macular degeneration. 1.085
Photodynamic therapy of pterygium with verteporfin: a preliminary report 1.071
null 1.035
Discrepancy in current central serous chorioretinopathy classification 1.020
Photodynamic therapy in human pterygium. A preliminar report 1.009
Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium 1.003
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 986
Photodynamic therapy of corneal neovascularization with verteporfin 975
Unfavorable effect of photodynamic therapy in a multiple detachment of pigment epithelium complicated by choroidal neovascularization 957
Comparison between a fundus camera and scanning laser ophthalmoscope in acquiring fluorescence emission in vitro. 949
En Face Choroidal Vascularity in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy 939
Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis 932
Pseudo-vitelliform macular detachment and cuticular drusen: Exclusion of 6 candidate genes 899
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. 895
Simultaneous presentation of idiopathic macular and posterior full-thickness retinal holes successfully treated with inverted internal limiting membrane flap technique. 854
null 851
Outcomes after giant peripheral retinotomy and anterior flap retinectomy for rhegmatogenous retinal detachments with advanced proliferative vitreoretinopathy using small gauge vitrectomy. 838
Repopulation of the retinal pigment epithelium after pigment epithelial rip. 796
Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review. 785
Photodynamic therapy with Verteporfin (Visudyne) for pterygium 773
Diagnosis of Age Related Macular Degeneration. 757
Erratum: Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study (BioMed Research International) 755
Macular hole formation following thermal laser photocoagulation in a patient with choroidal neovascular membrane and age-related macular degeneration. 739
Acute central serous chorioretinopathy and fundus autofluorescence 739
Optical Coherence tomography in a case of a double macular hole . 693
Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary Pterygium 686
Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide 672
Choroidal vascularity map in unilateral central serous chorioretinopathy: A comparison with fellow and healthy eyes 658
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 649
Effect of the First Year of COVID-19 Pandemic on Ophthalmological Practice: A Multi-Centre Italian Study with a Focus on Medico-Legal Aspects 646
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration 641
Late Effect of Irradiation of Choroidal Circulation. 628
Ocular Surface Changes Associated with Face Masks in Healthcare Personnel during COVID-19 Pandemic 627
null 620
Oral-ocular trans infection of Epstein Barr virus. A possible new way of transmission by wearing masks in the SARS-CoV-2 era 591
Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy 584
Unusual clinical manifestation of sclerochoroidal calcifications. 583
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 581
Central serous chorioretinopathy imaging biomarkers 537
Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous Chorioretinopathy 530
Non-neovascular age-related macular degeneration with subretinal fluid 529
Analysis of Fundus Autofluorescence in Patients With Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 523
Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study 518
Interocular asymmetry in distribution of leaks in central serous chorioretinopathy 507
Age-related macular degeneration and cognitive impairment show similarities in changes of neutral lipids in peripheral blood mononuclear cells 486
Outer retinal tubulations in central serous chorioretinopathy associated with choroidal neovascularisation 469
Two-Port “Dry Vitrectomy” as a New Surgical Technique for Rhegmatogenous Retinal Detachment: Focus on Macula-on Results 445
Correlation of sectoral choroidal vascularity with angiographic leakage in central serous chorioretinopathy 441
Quantitative and Qualitative Assessments of Retinal Structure with Variable A-Scan Rate Spectralis OCT: Insights into IPL Multilaminarity 440
INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE for MACULAR HOLE SURGERY WITHOUT EXTRA MANIPULATION of the FLAP 426
Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study 423
null 386
Relationship between nerve fiber layer hemorrhages and outcomes in central retinal vein occlusion 378
Totale 116.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.413 0 0 0 0 0 0 0 0 0 896 939 578
2021/20226.036 572 679 269 195 621 444 361 329 463 540 804 759
2022/202311.689 737 1.409 1.079 992 825 1.102 714 1.222 925 787 1.382 515
2023/202412.400 589 394 355 621 1.233 1.913 2.196 796 508 845 1.473 1.477
2024/202522.136 5.114 5.357 3.587 2.326 1.397 1.392 1.283 304 375 310 277 414
2025/20267.260 611 471 1.242 829 776 612 935 398 581 805 0 0
Totale 122.405